The market
Sourcing, quality, and why the review boards lie.
Roughly one in three gray-market products fails basic quality, whether in identity, purity, or quantity. We learned this the hard way. Here's the market as it actually is: the failure modes, the payment traps, and why a five-star vendor rating is worth nothing.
The risk map
The dangerous one. The wrong compound is in the vial. E.g. a labeled peptide that's actually a higher-potency one, and you overdose without knowing. Only mass spec catches it.
Synthesis byproducts and truncated sequences. The number vendors advertise, and the easiest to cherry-pick.
Underfilled vials. You pay for milligrams that aren't there. Common, rarely tested for.
Bacterial contamination from poor hygiene. Invisible to HPLC, injected straight into you.
A documented failure model
Independent testing has caught major vendors red-handed: one was rated the lowest grade across dozens of samples by an independent lab while self-reporting 98–99% purity, and then shut down. That's not an outlier, that's the pattern, which is why payment hygiene matters too: vendor shutdowns are common, so never store a card on file and never pre-load credit you can't get back.
Why review boards are worthless
- Affiliate-code shilling. The glowing review pays the reviewer when you buy.
- Paid ‘trusted vendor’ lists circulated in private chats.
- Astroturfed star ratings that move with marketing budgets, not quality.
- And the structural problem that anecdote can't escape: even an honest ‘worked for me’ is about a different batch than the one you'll receive.
Trust independent batch data. Distrust anecdote, and distrust anything that comes with a discount code attached.
The move
You don't need to trust a vendor. You need to verify a batch. Our verification standard is the checklist we use to do exactly that.